Actions

MDMA: Difference between revisions

An Avatar.Global Resource

m Text replacement - "{{template:connectionnav}}" to "<!-- connectionnav -->"
No edit summary
Line 1: Line 1:
<!-- connectionnav -->
{{template:draft}}
{{navmenu}}
{{navmenu}}
<h1 class="customtitle">{{FULLPAGENAME}}</h1>
<h1 class="customtitle">{{FULLPAGENAME}}</h1>
Line 15: Line 11:
==Notes==
==Notes==


{{template:cite}}
MDMA a "breakthrough" therapy for PTSD.<ref>Mitchell, Jennifer M., Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot’alora G., et al. “MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.” Nature Medicine 27, no. 6 (June 1, 2021): 1025–33. https://doi.org/10.1038/s41591-021-01336-3.</ref>
 
==Footnotes==


<references />
{{endstuff}}


{{template:references}}


[[category:terms]][[Is a::Connection Supplement| ]]
[[category:terms]][[category:lightningpath]][[Is a::Connection Supplement| ]]

Revision as of 17:03, 9 December 2021

MDMA

List of Connection Supplements

Notes

MDMA a "breakthrough" therapy for PTSD.[1]

Citation and Legal

Treat the SpiritWiki as an open-access online monograph or structured textbook. You may freely use information in the SpiritWiki; however, attribution, citation, and/or direct linking are ethically required.

Footnotes

  1. Mitchell, Jennifer M., Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot’alora G., et al. “MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.” Nature Medicine 27, no. 6 (June 1, 2021): 1025–33. https://doi.org/10.1038/s41591-021-01336-3.